Our patient’s treatment regimen with NSAIDs changed to disease-modifying
anti-rheumatic drugs (DMARDs) administration of hydroxychloroquine with
a daily dose of 400mg.
Our patient was discharged home after 2 weeks of admission with the
diagnosis of acute fibrinous pericarditis as the first manifestation of
SLE. He had weekly follow-up visits with TTE examinations.
On his sixth week of anti-inflammatory treatment at his follow-up visit,
all of his signs and symptoms were resolved. TTE study showed that all
the pericardial fibrin strands and effusion were completely resolved
(Figure 6 (A) and (B)) (Supplementary video 3). Hemodynamic of
constrictive pattern was completely reversed in doppler study of mitral
valve inflow with no respiratory variations.